Literature DB >> 12181435

Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.

Adrian Newman-Tancredi1, Didier Cussac, Laetitia Marini, Mark J Millan.   

Abstract

Although serotonin 5-HT(1A) receptors couple to several Gi/o G-protein subtypes, little is known concerning their differential activation patterns. In this study, in membranes of Chinese hamster ovary cells expressing h5-hydroxytryptamine(1A) receptors (CHO-h5-HT(1A)), isotherms of 5-HT-stimulated guanosine-5'-O-(3-[(35)S]thio)-triphosphate ([(35)S]GTPgammaS) binding were biphasic, suggesting coupling to multiple G-protein subtypes. The high potency component was abolished by preincubation with an antibody recognizing Galpha(i3) subunits and was resistant to induction of [(35)S]GTPgammaS dissociation by unlabeled GTPgammaS, thus yielding a bell-shaped concentration-response isotherm. To directly investigate Galpha(i3) activation, we adopted an antibody-capture/scintillation proximity assay. 5-HT and other high-efficacy agonists yielded bell-shaped [(35)S]GTPgammaS binding isotherms, with peaks at nanomolar concentrations. As drug concentrations increased, Galpha(i3) stimulation progressively returned to basal values. In contrast, the partial agonists (-)-pindolol and 4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine (S15535) displayed sigmoidal stimulation isotherms, whereas spiperone and other inverse agonists sigmoidally inhibited [(35)S]GTPgammaS binding. Agonist-induced stimulation and inverse agonist-induced inhibition of Galpha(i3) activation were i) abolished by pretreatment of CHO-h5-HT(1A) cells with pertussis toxin; ii) reversed by the selective 5-HT(1A) antagonist (N-[2-[4-(2-methoxy-phenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)-cyclohexane-carboxamide) fumarate (WAY100,635), and iii) absent in nontransfected CHO cell membranes. 5-HT isotherms could be modified by altering sodium concentration; only stimulatory actions were observed at 300mM NaCl, whereas only inhibitory actions were seen at 10 mM NaCl. Furthermore, bell-shaped isotherms were not detected at short incubation times, suggesting time-dependent changes in receptor/Galpha(i3) coupling. Taken together, these data show that low but not high concentrations of high-efficacy 5-HT(1A) agonists direct receptor signaling to Galpha(i3). In contrast, partial agonists favor h5-HT(1A) receptor signaling to Galpha(i3) over a wide concentration range, whereas inverse agonists inhibit constitutive Galpha(i3) activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181435     DOI: 10.1124/mol.62.3.590

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  12 in total

1.  Modulation of 5-HT(1A) receptor-mediated Ca(2+) responses by co-expression with various recombinant G(alpha) proteins in CHO-K1 cells.

Authors:  Thierry Wurch; Petrus J Pauwels
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-16       Impact factor: 3.000

Review 2.  Rho kinase as a target for cerebral vascular disorders.

Authors:  Lisa M Bond; James R Sellers; Lisa McKerracher
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

3.  Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39.

Authors:  Frederic Bassilana; Adam Carlson; Jennifer A DaSilva; Bianka Grosshans; Solange Vidal; Valerie Beck; Barbara Wilmeringwetter; Luis A Llamas; Todd B Showalter; Pascal Rigollier; Aaron Bourret; Arun Ramamurthy; Xu Wu; Fred Harbinski; Samantha Plonsky; Lac Lee; Heinz Ruffner; Paola Grandi; Markus Schirle; Jeremy Jenkins; Andreas W Sailer; Tewis Bouwmeester; Jeffrey A Porter; Vic Myer; Peter M Finan; John A Tallarico; Joseph F Kelleher; Klaus Seuwen; Rishi K Jain; Sarah J Luchansky
Journal:  Nat Chem Biol       Date:  2014-03-16       Impact factor: 15.040

4.  h5-HT(1B) receptor-mediated constitutive Galphai3-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HT.

Authors:  Adrian Newman-Tancredi; Didier Cussac; Laetitia Marini; Manuelle Touzard; Mark J Millan
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 5.  Transcriptional regulation of the 5-HT1A receptor: implications for mental illness.

Authors:  Paul R Albert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

6.  G Protein-Coupled Receptors Incorporated into Rehydrated Diblock Copolymer Vesicles Retain Functionality.

Authors:  M Gertrude Gutierrez; Farzad Jalali-Yazdi; Justin Peruzzi; Carson T Riche; Richard W Roberts; Noah Malmstadt
Journal:  Small       Date:  2016-08-16       Impact factor: 13.281

7.  Measuring substrate binding and affinity of purified membrane transport proteins using the scintillation proximity assay.

Authors:  Daniel Harder; Dimitrios Fotiadis
Journal:  Nat Protoc       Date:  2012-08-02       Impact factor: 13.491

8.  Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist.

Authors:  A Newman-Tancredi; J-C Martel; M-B Assié; J Buritova; E Lauressergues; C Cosi; P Heusler; L Bruins Slot; F C Colpaert; B Vacher; D Cussac
Journal:  Br J Pharmacol       Date:  2009-01-12       Impact factor: 8.739

Review 9.  Functional approaches to the study of G-protein-coupled receptors in postmortem brain tissue: [35S]GTPγS binding assays combined with immunoprecipitation.

Authors:  Rebeca Diez-Alarcia; Yuji Odagaki; Patricia Miranda-Azpiazu; Ane M Gabilondo; J Javier Meana; Itziar Muneta-Arrate
Journal:  Pharmacol Rep       Date:  2021-04-20       Impact factor: 3.024

10.  Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl- 11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione in nonhuman primates.

Authors:  J S Dileep Kumar; Jaya Prabhakaran; Vattoly J Majo; Matthew S Milak; Shu-Chi Hsiung; Hadassah Tamir; Norman R Simpson; Ronald L Van Heertum; J John Mann; Ramin V Parsey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-13       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.